SecBot SecBot
144 ·Filed Jun 29, 2026

DYN

Dyne Therapeutics, Inc.
BEARISH
Impact 4/10
Horizonweeks Processed4mo ago SEC0001628280-26-046094
Actionable Insight ▼ Bearish

Monitor for actual execution of these sales on Form 4 filings. The combined Atlas Venture filings, alongside 9 other insider sells in the past 30 days totaling $10.2M, suggest a pattern of insider distribution. While the dollar amount is not large relative to market cap, the signal from a lead venture investor trimming is notable. Watch for any clinical data readouts or pipeline updates that could alter the selling rationale.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$22.21
T+0 close · Jun 29, 2026 · via day close
Latest settled
−26.92%
T+60 · $16.23
Vs SPY
−29.74%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 30 $22.21entry
  2. T+1 · 5mo ago −1.89%α −1.76% · $21.79
  3. T+5 · 4mo ago +2.84%α +2.23% · $22.84
  4. T+20 · 4mo ago +15.40%α +16.43% · $25.63
  5. T+60 · 8w ago −26.92%α −29.74% · $16.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atlas Venture Fund XI, L.P. and Atlas Venture Opportunity Fund I, L.P., two affiliated venture capital funds, filed Form 144 notices on June 29, 2026, indicating intent to sell a combined 102,969 shares of Dyne Therapeutics (DYN) valued at approximately $2.16 million. As early investors, these sales represent a partial exit by a major insider, though the dollar amount is modest relative to DYN's $3.5B market cap.

Key Facts

  • Atlas Venture Fund XI, L.P. files Form 144 to sell 102,969 shares of DYN common stock.
  • Atlas Venture Opportunity Fund I, L.P. also files a Form 144 on the same date (share count not specified in available text).
  • Total proposed sale value is approximately $2,156,170.86 based on the first filing.
  • Shares were acquired in a private placement on July 31, 2020.
  • The filing is an advance notice of intent to sell; the actual sale may not occur.
  • Recent insider activity (30d) shows 9 sells totaling $10.2M, indicating ongoing insider selling pressure.

Financial Impact

Proposed sale of ~102,969 shares worth ~$2.16M, representing a small fraction of DYN's $3.5B market cap.

dilutioninsider selling

Risk Factors

  • Insider selling by a major early investor may signal reduced confidence in near-term catalysts.
  • Additional unregistered sales by affiliates could add overhang.
  • The company has no approved products; clinical-stage biotech risk is elevated.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (DYN), Batch item 10001628280-26-046094
Document: 0001628280-26-046094-index.html0001628280-26-046093
Document: 0001628280-26-046094.txt0001628280-26-046094
144 Filing (DYN), Batch item 40001628280-26-046093

Track record

54 reports on DYN

Performance horizon

12 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (10h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 29, 2026